Lilly (Eli) and Co
Article Abstract:
The price appreciation potential of the shares of Lilly (Eli) and Co. for the years 2010-2012 is discussed. The Indianapolis, Indiana-based company develops, manufactures, and markets pharmaceuticals and animal health products.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Eli Lilly and Co., LLY
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Valeant Pharmac
Article Abstract:
The price appreciation potential of the shares of Valeant Pharmaceutical for the years 2010-2012 is discussed. The Costa Mesa, California-based company is a manufacturer of drugs and other medical products.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Valeant Pharmaceuticals International, VRX
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Pharmaceutical industry, Stocks, Securities, Stock prices, Company securities, Analyst report
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.